Skip to main content
Figure 5 | Malaria Journal

Figure 5

From: The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership

Figure 5

Long-term stability study of ASAQ bilayer Aluminium blistered tablets in ambient conditions. AS & AQ content (Y axis) and DHA content (cited above histogrammes) of batch n° 30154C04. Key: AS = artesunate; DHA = dihydroartesunate; AQ = amodiaquine; black dotted lines: specifications of AS&AQ content (100 ± 5%). Mean of 20.

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us